Oct 2, 2024, 01:00 AM by User Not Found

Bio-IT World | The longstanding reality for most individuals infected with human immunodeficiency virus (HIV) is a lifetime of taking antiretroviral therapy (ART). But the creation of an HIV-like virus particle that both reduces viral reservoirs and boosts the immune system could make it possible for at least half of all patients to achieve long-term control of the virus after a brief stint of treatment.

Oct 1, 2024, 07:32 AM by

VieCure Inc. announced the completion of a $45 million financing led by Northpond Ventures and the appointment of industry veteran Richard Daly as chairman of the board of directors.

Oct 1, 2024, 07:32 AM by

Oct 1, 2024, 01:00 AM by User Not Found

Bio-IT World | In a paper published last month in Brain, researchers explored data from 24 past Alzheimer’s Disease trials and posited a new theory for why the most recent drugs have shown some success against the disease, and senior author Alberto Espay issued an open data challenge for pharma companies working in the space.

Sep 30, 2024, 06:10 AM by

CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest addition to its enterprise software platform

Sep 27, 2024, 07:47 AM by

ResultsCX, a provider of Customer Experience Management (CXM) services to leading global companies including Fortune 100 and 500 firms, today announced it was honored as a Major Contender in Everest Group’s Customer Experience Management (CXM) Services PEAK Matrix® Assessment (Americas region) for the fourth consecutive year. This recognition underlines the company’s ongoing expansion and commitment to supporting organizations across industries in optimizing consumer experience (CX) and driving growth.

Sep 26, 2024, 08:16 AM by

The Clinical Research Data Sharing Alliance (CRDSA), a multi-stakeholder consortium that serves the clinical research data ecosystem, has announced the publication of two new standards; the Standard for Sharing Clinical Study Data and the Standard for Secondary Analysis of Clinical Study Data. CRDSA developed these standards in response to common challenges faced by both data contributors and researchers. These new standards aim to facilitate the responsible sharing and use of anonymized individual patient data from clinical studies to support the research community and accelerate the discovery and delivery of new therapies to patients.

Sep 26, 2024, 08:16 AM by

Sep 26, 2024, 08:16 AM by

Takara Bio Europe has announced the launch of the Shasta™ Single-Cell System, a high-throughput NGS solution enabling novel biomarker discovery in oncology research, at the 2024 Human Cell Atlas General Meeting. This comprehensive system combines well-validated chemistries with user-friendly bioinformatics tools, allowing researchers to mine more genomic and transcriptomic information from a much greater number of cells than previously possible, all while reducing both time and costs. The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit increases throughput by processing up to 1,500 cells per run, compared to current technologies which are limited to 384 single cells, while also enabling the detection of single-cell level CNV events via shallow sequencing. Its ability to detect RNA biotypes, such as non-polyadenylated lncRNAs, otherwise missed by current droplet-based technologies represents a significant advancement over traditional plate-based full-length RNA-seq and high-throughput mRNA-seq methods.

Sep 26, 2024, 01:00 AM by User Not Found

Bio-IT World | ArsenalBio plans to advance their lead programs through development invests in candidates for solid tumor cancers based on its proprietary T cell engineering technology; eGenesis moves to a first-in-human study for kidney transplant; SpectraWAVE will advance commercial expansion and product additions to their 510k-cleared HyperVue Imaging System; and more.

Sep 25, 2024, 09:09 AM by

Duke Street Bio Ltd has announced that the European Medicines Agency (EMA) has granted approval to commence a clinical trial for its highly-selective PARP1 inhibitor, DSB2455.

Sep 25, 2024, 09:09 AM by

Endor Labs, the leader in open source software security, today announced that industry veteran Karl Mattson has been named as the company’s first Chief Information Security Officer (CISO).

Sep 25, 2024, 09:09 AM by

Phastar’s Data Analytics and Visualization Portal and commitment to high ESG standards secures shortlist spot at the 20th Anniversary Scrip Awards

Sep 25, 2024, 09:09 AM by

The PIREG-545 impulse heat seal controller offers significant advantages in the medical and pharmaceutical markets. Its quick and precise control offers repeatable and consistent heat seal results critical for processes in need of validation as many life science applications demand. The PIREG-545 enhances quality control and compliance to industry standards.

Sep 25, 2024, 01:00 AM by User Not Found

Bio-IT World | Illumina welcomed the European Court of Justice's judgment ruling that the European Commission did not have jurisdiction over Illumina's acquisition of GRAIL; Moffitt Cancer Center announced a strategic collaboration with AstraZeneca that aims to accelerate the development of cell therapies, specifically chimeric antigen receptor T cell and T cell receptor therapies; 10x Genomics’ Chromium Single Cell Gene Expression and Xenium In Situ platforms in publication; and more.

Sep 24, 2024, 09:08 AM by

Sep 24, 2024, 01:00 AM by User Not Found

Bio-IT World | What Wegovy has done for people who want to lose weight but dislike the work involved might one day find its match with a pill that pumps up a person’s desire to exercise—all by adjusting their level of interleukin 15 (IL-15), a cytokine that in the brain stimulates locomotor activity. At least that’s one of the promising possibilities dredged up by a study in mice finding a muscle-brain pathway controlling “eagerness to train more when we exercise."

Sep 20, 2024, 01:00 AM by User Not Found

Bio-IT World | With the wealth of population-scale projects going on, we have entered a golden age of genomics. Based on efforts such as the All of Us program in the U.S. and the UK Biobank, among many others, we are poised to discover more than we ever knew about natural genetic diversity, what’s considered “normal” human biology, and the continuum of health and disease.

Sep 19, 2024, 10:07 AM by

The Biomedical Advanced Research and Development Authority (BARDA) has selected MATTER to lead the new Digital Health Hub as part of the BARDA Accelerator Network. The hub, called Paratus, will support the development of next-gen digital health technologies to address health security threats.

Sep 19, 2024, 10:07 AM by

Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology represents a significant advancement in nucleic acid purification.